Gesundheitswelt Chiemgau AG Net Assets
Gesundheitswelt Chiemgau AG net assets. Based on the latest financial reports, Gesundheitswelt Chiemgau AG (JTH) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Gesundheitswelt Chiemgau AG (JTH) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | 17.43% |
| 5-Year Change | 33.92% |
| 10-Year Change | N/A |
| Growth Volatility | 25.06 |
Net Assets of Gesundheitswelt Chiemgau AG (2015–2024)
Net assets of Gesundheitswelt Chiemgau AG from 2015 to 2024. This chart illustrates how Gesundheitswelt Chiemgau AG's net assets have evolved over time, based on quarterly financial data. See JTH net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Gesundheitswelt Chiemgau AG (2015–2024)
The table below shows the annual net assets of Gesundheitswelt Chiemgau AG from 2015 to 2024. For live market cap and overall valuation, see JTH company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €38.15 Million ≈ $44.61 Million |
+2.67% |
| 2023-12-31 | €37.16 Million ≈ $43.45 Million |
+8.61% |
| 2022-12-31 | €34.22 Million ≈ $40.00 Million |
+10.22% |
| 2021-12-31 | €31.04 Million ≈ $36.29 Million |
+8.96% |
| 2020-12-31 | €28.49 Million ≈ $33.31 Million |
+13.63% |
| 2019-12-31 | €25.07 Million ≈ $29.31 Million |
+15.19% |
| 2018-12-31 | €21.77 Million ≈ $25.45 Million |
+13.20% |
| 2017-12-31 | €19.23 Million ≈ $22.48 Million |
+12.85% |
| 2016-12-31 | €17.04 Million ≈ $19.92 Million |
+89.62% |
| 2015-12-31 | €8.98 Million ≈ $10.50 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Gesundheitswelt Chiemgau AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 501.0% over the analyzed period, indicating profitable operations and earnings retention.
Gesundheitswelt Chiemgau AG Net Assets Breakdown (December 2024)
Gesundheitswelt Chiemgau AG net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €34.91 Million | 91.50% |
| Other Components | €3.24 Million | 8.50% |
| Total Equity | €38.15 Million | 100.00% |
Gesundheitswelt Chiemgau AG Competitors by Market Cap
The table below lists competitors of Gesundheitswelt Chiemgau AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AppSpotr AB
ST:APTR
|
$28.96 Million |
|
Verimatrix
PA:VMX
|
$28.97 Million |
|
Lyka Labs Limited
NSE:LYKALABS
|
$28.98 Million |
|
Serinus Energy Inc.
WAR:SEN
|
$28.98 Million |
|
Skyline Builders Group Holding Limited
NASDAQ:KAZR
|
$28.93 Million |
|
SAHYADRI INDUSTRIES ORD (BSE)
NSE:SAHYADRI
|
$28.93 Million |
|
DS Sigma Holdings Berhad
KLSE:0269
|
$28.92 Million |
|
Finetechnix. Co.Ltd
KQ:106240
|
$28.92 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gesundheitswelt Chiemgau AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 37,161,011 to 38,154,837, a change of 993,826 (2.7%).
- Net income of 3,153,305 contributed positively to equity growth.
- Dividend payments of 1,053,000 reduced retained earnings.
- Other factors decreased equity by 1,106,479.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €3.15 Million | +8.26% |
| Dividends Paid | €1.05 Million | -2.76% |
| Other Changes | €-1.11 Million | -2.9% |
| Total Change | €- | 2.67% |
Book Value vs Market Value Analysis
This analysis compares Gesundheitswelt Chiemgau AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.65x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.05x to 0.65x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €256.36 | €12.70 | x |
| 2018-12-31 | €290.21 | €12.70 | x |
| 2019-12-31 | €334.31 | €12.70 | x |
| 2020-12-31 | €379.88 | €12.70 | x |
| 2021-12-31 | €413.91 | €12.70 | x |
| 2022-12-31 | €17.55 | €12.70 | x |
| 2023-12-31 | €19.06 | €12.70 | x |
| 2024-12-31 | €19.57 | €12.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gesundheitswelt Chiemgau AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.26%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.03%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 2.18x
- Recent ROE (8.26%) is below the historical average (17.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 35.95% | 6.63% | 1.99x | 2.72x | €2.33 Million |
| 2016 | 47.26% | 15.95% | 1.72x | 1.72x | €6.35 Million |
| 2017 | 11.39% | 3.95% | 0.74x | 3.87x | €266.61K |
| 2018 | 12.02% | 4.46% | 0.78x | 3.45x | €440.12K |
| 2019 | 13.79% | 5.49% | 0.83x | 3.01x | €949.79K |
| 2020 | 15.17% | 8.18% | 0.69x | 2.69x | €1.47 Million |
| 2021 | 13.12% | 6.76% | 0.78x | 2.48x | €967.80K |
| 2022 | 11.64% | 6.04% | 0.85x | 2.26x | €561.56K |
| 2023 | 10.45% | 5.34% | 0.91x | 2.15x | €166.79K |
| 2024 | 8.26% | 4.03% | 0.94x | 2.18x | €-662.18K |
Industry Comparison
This section compares Gesundheitswelt Chiemgau AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gesundheitswelt Chiemgau AG (JTH) | €- | 35.95% | N/A | $28.95 Million |
| Covestro AG (1COV) | $6.68 Billion | -3.98% | 1.04x | $11.10 Billion |
| CENTESSA PHARMACEUTICALS (260) | $401.55 Million | -58.71% | 0.44x | $5.35 Billion |
| 2invest AG (2INV) | $61.58 Million | -34.16% | 0.01x | $70.69 Million |
| COINSHARES I. LS-000247 (3TW) | $-1.41K | 0.00% | 0.00x | $472.53 Million |
| Adaptimmune Therapeutics plc (473A) | $123.64 Million | -110.94% | 0.47x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.72 Million | -14.34% | 0.35x | $4.05K |
| GENOR BIOPHARMA DL-00002 (67N0) | $2.49 Billion | -34.70% | 0.15x | $93.97 Million |
| BENO Holding AG (BENH) | $16.45 Million | 13.33% | 2.75x | $72.92K |
| Biotest Aktiengesellschaft (BIO) | $253.37 Million | 11.10% | 1.34x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $110.79 Million | 17.87% | 2.36x | $656.94 Million |
About Gesundheitswelt Chiemgau AG
Gesundheitswelt Chiemgau AG, together with its subsidiaries, provides health and wellness services in Germany. It operates clinics for orthopedic treatment and rehabilitation, geriatric rehabilitation, psychosomatic hospital treatment, oncology and cardiology, psychosomatic hospital treatment, and psychosomatics and psychotherapy; center of sports and rehabilitation diagnostics; and ambulatory an… Read more